Persistent Anemia After Implantation of the Total Artificial Heart

详细信息	查看全文 | 推荐本文 |

• 作者：Anit K. Mankad ; MD¹ ; Daniel G. Tang ; MD² ; William B. Clark ; MD ; MS³ ; Maureen Flattery ; NP² ; Suzanne Harton ; NP² ; Gundars J. Katlaps ; MD² ; Warren K. Stribling ; MD¹ ; Richard H. Cooke ; MD¹ ; Michael L. Hess ; MD¹ ; Vigneshwar Kasirajan ; MD² ; Keyur B. Shah ; MD¹ ; ^{kshah@mcvh-vcu.edu}
• 关键词：Total artificial heart ; anemia ; left ventricular assist device ; cardiac transplantation
• 刊名：Journal of Cardiac Failure
• 出版年：2012
• 期刊代码：162_10719164
• 类别：med
• 出版时间：June, 2012
• 卷：18
• 期：6
• 页码：433-438
• 文件大小：261 K

摘要

Background

The total artificial heart (TAH) replaces the heart with 2 pneumatic pumps and 4 tilting disk mechanical valves. It was hypothesized that patients receiving TAH support have persistent hemolysis that resolves after heart transplantation (HT).

Methods and Results

Hematocrit (HCT) was compared in patients on TAH to left ventricular assist device (LVAD) support for bridge to HT. Data were compared with m>tm> tests. The TAH (n聽= 36; mean age 47 卤 13 years) and LVAD patients (n聽= 14; mean age 53 卤 12 years) were supported for a median of 83 (interquartile range [IQR] 43-115) and 106 days (IQR 84-134), respectively. Hematocrit was similar between the TAH and LVAD patients (34 卤 6%vs 37 卤 5%; m>Pm>聽= .07) at baseline. After placement, TAH patients had lower HCT at 2 (20 卤 2%vs 24 卤 3%), 4 (22 卤 3%vs 26 卤 3%), 6 (22 卤 4%vs 30 卤 4%), and 8聽weeks (23 卤 4%vs 33 卤 5%; m>Pm> < .001 for all). There were no differences in HCT at 1 (30 卤 4%vs 29聽卤 7%; m>Pm>聽= .42) and 3 months (35 卤 7%vs 35 卤 4%; m>Pm>聽= .98) after removal of the devices for HT. TAH patients had undetectable haptoglobin in 96%of assessments, increased lactate dehydrogenase (1,128 卤 384 units/L), and detectable plasma free hemoglobin in 40%of measurements (21 卤 15 mg/dL). High sensitivity C-reactive protein (52 卤 50 mg/dL) was elevated, and reticulocyte production index was decreased (1.6 卤 0.6).

Conclusions

Patients implanted with a TAH have persistent anemia that resolves only after HT. The association of hemolysis, ineffective erythropoiesis, and inflammation with the TAH warrants further study.